| Autor: |
Albensi BC; NPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108, USA., Alasti N, Mueller AL |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of neuroscience research [J Neurosci Res] 2000 Oct 15; Vol. 62 (2), pp. 177-85. |
| DOI: |
10.1002/1097-4547(20001015)62:2<177::AID-JNR3>3.0.CO;2-D |
| Abstrakt: |
The role of the NMDA receptor (NMDAR) in long-term potentiation (LTP) is now well established. All potent NMDAR antagonists known to date inhibit the induction of LTP at the Schaffer collateral-CA1 pyramidal cell synapse in rat hippocampus, regardless of their site and mechanism of action. Arylalkylamine toxins are noncompetitive NMDAR antagonists in the mammalian central nervous system (CNS). The synthetic toxins argiotoxin-636 (Arg-636), Joro spider toxin (JSTX-3), alpha-agatoxin-489 and -505 (Agel-489 and Agel-505) and philanthotoxin-433 (delta-PhTX) were found in the present study to have no effect on the induction of LTP in the Schaffer collateral-CA1 pyramidal cell pathway in rat hippocampal slices maintained in vitro. Arylalkylamine toxins represent a class of potent NMDAR antagonists that fail to affect hippocampal LTP, and thus provide novel structural leads for the development of NMDAR antagonists that do not impair cognition. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text